Mangrove Partners’s Isleworth Healthcare Acquisition Corporation Warrant ISLEW Stock Holding History

Mangrove Partners’s Portfolio ISLEW Stock Details ISLEW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-93,966	Closed	-$936K	–	588
2022 Q2	$936K	Hold	93,966	–	–	0.05%	397
2022 Q1	$930K	Buy	+93,966	New	+$31.2K	0.05%	372
2021 Q3	–	Sell	-240,177	Closed	-$168K	–	429
2021 Q2	$168K	Buy	240,177 +43,736	+22%	+$25.9K	0.02%	301
2021 Q1	$92K	Buy	+196,441	New	+$94K	0.01%	285

Mangrove Partners's ISLEW Position: Q3 2022 in Review

Mangrove Partners sold out of Isleworth Healthcare Acquisition Corporation Warrant (ISLEW) in Q3 2022, closing a stake of 93,966 shares — an estimated $936K sold.

Mangrove Partners first reported a position in ISLEW in Q1 2021 and held it in 4 quarters. The position peaked at $936K in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLEW as of Q3 2022.

Mangrove Partners reported no remaining Isleworth Healthcare Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
Mangrove Partners sold 93,966 Isleworth Healthcare Acquisition Corporation Warrant shares in Q3 2022, an estimated $936K.
Mangrove Partners first reported a position in Isleworth Healthcare Acquisition Corporation Warrant in Q1 2021 and held it in 4 quarters.
Mangrove Partners's Isleworth Healthcare Acquisition Corporation Warrant position peaked at $936K in Q2 2022.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Warrant as of Q3 2022.

Based on Mangrove Partners's 13F filing for Q3 2022, filed 14 Nov 2022.